The global hernia mesh devices market is poised for steady growth, with an estimated compound annual growth rate (CAGR) of 3.4% during the forecast period, according to a comprehensive analysis by Future Market Insights (FMI). Valued at approximately USD 4.6 billion in 2022, the market is projected to reach USD 6.5 billion by 2032, reflecting the strong demand for effective and innovative medical solutions.
The primary driver of this growth is the increasing prevalence of inguinal hernias, which account for 80% of all hernia cases globally. With inguinal hernias being ten times more common in men than women, this condition continues to represent a significant healthcare burden. The rising number of hernia cases is propelling the demand for advanced hernia mesh devices aimed at improving patient outcomes and enhancing the quality of life for individuals affected by these conditions.
“Hernia mesh devices play a critical role in addressing the growing cases of inguinal hernias, a condition that affects millions worldwide,” said FMI. “The market is seeing a surge in demand for advanced, patient-centric solutions that not only improve surgical outcomes but also reduce recurrence rates, contributing to better long-term results for patients.”
North America is set to experience significant growth throughout the forecast period, with a projected CAGR of 3.4%. The region benefits from favorable reimbursement policies that encourage patients to opt for laparoscopic surgery, coupled with comprehensive payment codes and industry-wide support, leading to higher adoption rates of hernia mesh devices. The continued innovation of products, such as TELA Bio, is further boosting the market’s revenue potential in North America.
As the hernia mesh devices market evolves, healthcare stakeholders, including providers and manufacturers, stand to benefit from ongoing advancements in technology. The growing focus on patient-centric solutions and innovative medical devices ensures that the market will continue to expand, offering improved options for both healthcare providers and patients alike.
The future of hernia mesh devices is bright, with continuous advancements designed to improve treatment outcomes and quality of life for millions of patients globally.
Key Takeaways: Hernia Mesh Devices Market from 2022 to 2032
- The global hernia mesh devices market was valued at USD 4.6 billion in 2022 and is expected to reach USD 6.5 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 3.4%.
- Inguinal hernias are projected to remain the most common type, accounting for roughly 80% of all hernia procedures.
- The United States is anticipated to hold the largest market share, exceeding 34% by 2032. This makes it a prime target market for hernia mesh device manufacturers, particularly those specializing in synthetic mesh.
- Synthetic mesh devices are expected to see strong growth within the US market.
Dive Deep into the Market Trends: Access the Full Hernia Mesh Devices Market Report
Hernia Mesh Devices Market: Competition Insights
Most of the key players in hernia mesh devices market have been focusing on obtaining approvals from regulatory authorities. The key companies operating in the Hernia Mesh Devices market include Medtronic plc, Ethicon, and W. L. Gore and Associates, Inc., Atrium Medical Technologies, B. Braun Melsungen AG, PRIMEQUAL SA, Becton, Dickinson, and Company, Deep Blue Medical Inc., Dipromed Srl, BioCer Entwicklungs-GmbH, Betatech Medical, Sinolinks Medical Innovation, Inc, Aspide Medical S.A.S., Meril Life Sciences Pvt. Ltd., Herniamesh Srl., Changzhou Medical Equipment General Factory Co., Ltd, Gem Srl, SAMYANG HOLDING CORPORATION, Katsan Katgut Sanayi Ve Ticaret Anonim Sirketi, Novus Scientific AB.
The key recent developments of Hernia Mesh Devices manufacturers are as follows:
- Novus Scientific AB received FDA approval in March 2020 for TIGR Matrix Surgical Mesh, which is indicated for use in procedures involving soft tissue repairs, such as hernia repair or other soft tissue-related defects.
- Becton, Dickinson, and Company received FDA clearance in July 2020 for 3DMax MID Anatomical Mesh, which is indicated for use in soft tissue reinforcement and inguinal hernia repair.
- Deep Blue Medical Inc. received FDA approval to begin selling its new hernia mesh product in August 2020. Because of the product’s promising sales prospects, the company recently announced that investors have invested USD 3.4 million in the company.
Key Segments:
Key Segments Covered in Hernia Mesh Devices Market Survey
Hernia Mesh Devices Market by Mesh Type:
- Biological Mesh
- Synthetic Mesh
Hernia Mesh Devices Market by Hernia Type:
- Inguinal Hernia
- Incisional Hernia
- Femoral Hernia
- Others
Hernia Mesh Devices Market by Region:
- North America Hernia Mesh Devices Market
- Latin America Hernia Mesh Devices Market
- Europe Hernia Mesh Devices Market
- South Asia Hernia Mesh Devices Market
- East Asia Hernia Mesh Devices Market
- Oceania Hernia Mesh Devices Market
- Middle East & Africa Hernia Mesh Devices Market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube